Seaweed extract shows promise in protecting neurons in Parkinson’s disease

FHS
August 7, 2024
10:48 pm

Ecklonia cava polyphenols (ECPs) show promise in reducing neuronal damage caused by rotenone in Parkinson’s disease (PD) by activating the Nrf2-ARE pathway, highlighting their potential as a neuroprotective treatment.

Pharmalittle: Sanofi plans to spin off its consumer health biz; EMA says no evidence GLP-1 drugs linked to thyroid cancer

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal

October 27, 2023

The little-known bill that made drugs more affordable

This is Part 4 of “Behind the Counter,” an in-depth video series demystifying the complex world of patents and drug pricing. Years ago, when a

September 10, 2024

The safety and efficacy of the nano-based COVID-19 vaccine

A recent study evaluated the safety and efficacy of the GBP510 vaccine against SARS-CoV-2 infection.

September 12, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.